Table 2. Evaluation of the assay system 2: lac2 as the marker gene.
1st RNAi | 2nd RNAi | Initial # of larvae | # survived | # of 2nd instar | lac2 | WT | suppression | |
250 bpAgo2 (5 ug/mL) | 250 bp lac2 (5 ug/mL) | co-feeding | 30 | 26 | 19 | 18 | 1 | 5% |
250 bp Dcr2 (5 ug/mL) | 250 bp lac2 (5 ug/mL) | co-feeding | 28 | 21 | 21 | 17 | 4 | 19% |
250 bp KA (5 ug/mL) | 250 bp lac2 (5 ug/mL) | co-feeding | 27 | 24 | 24 | 17 | 7 | 29% |
250 bpAgo2 (5 ug/mL) | 250 bp lac2 (5 ug/mL) | sequential | 30 | 22 | 16 | 15 | 1 | 6% |
250 bpDcr2 (5 ug/mL) | 250 bp lac2 (5 ug/mL) | sequential | 28 | 13 | 12 | 12 | 0 | 0% |
250 bp KA (5 ug/mL) | 250 bp lac2 (5 ug/mL) | sequential | 27 | 20 | 15 | 11 | 4 | 26% |
The amount of the maker gene dsRNA and the feeding scheme influence the outcome of the assay. The second instar larvae were categorized into the Lac2 phenotype (i.e. the second RNAi worked) and the WT phenotype (i.e. the second RNAi is suppressed). The suppression of the second RNAi phenotype by the initial RNAi was evaluated as the proportion of the WT larvae in the survived second instar larvae (Suppression).